polaris retatrutide Weight Loss & Metabolic Peptides Australia Retatrutide (Reta GLP-3) - 99%+

Phase 3 safety data will be necessary to confirm whether CT-388 inherits tirzepatide's favorable safety differential

Sellers sometimes position these products as not for human consumption and market them as: Research peptides Research-use-only vials Peptide powders or reconstituted injections Prescription-only compounded-style retatrutide products However, none of these descriptions mean the product is safe or appropriate for human use

E., Roden, M., & Ratziu, V

Action against misleading ads On 10 March, 2026, the DCGI issued a comprehensive advisory to all drug manufacturers ordering them to stop misleading advertisements and any promotion that could encourage people to use GLP-1 drugs without prescription